Health-related quality of life in transplant ineligible newly diagnosed multiple myeloma patients treated with either thalidomide or lenalidomide-based regimen until progression: a prospective, open-label, multicenter, randomized, phase 3 study
暂无分享,去创建一个
U. Mellqvist | P. Sonneveld | B. van der Holt | B. Lissenberg-Witte | A. Waage | N. Abildgaard | E. Haukås | J. Coenen | M. Hansson | P. Gimsing | M. Levin | G. Bos | S. Klein | S. Zweegman | N. V. D. van de Donk | B. Tanis | M. Durian | L. K. Nielsen | M. Hinge | H. Sinnige | D. Szatkowski | A. V. D. van der Velden | H. Visser-Wisselaar | R. Brouwer | K. G. van der Hem | M. Salomo | W. Deenik | M. Westerman | C. Stege | R. Leys